Literature DB >> 11401915

Blood determinations of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine: correlations with diet.

L A Poirier1, C K Wise, R R Delongchamp, R Sinha.   

Abstract

An increasing number of both clinical and experimental studies have shown an association between deficiencies of the dietary sources of physiological methyl groups and cancer formation. The critical metabolic intermediate in a determination of methylation status is S-adenosylmethionine (SAM), the body's chief physiological methyl donor. The present study examined the erythrocyte levels of SAM and of its demethylated metabolite S-adenosylhomocysteine (SAH) in 66 normal subjects (33 men and 33 women), whose blood had been drawn at days 0, 7 and 14 of an experimental period during which they were fed a fixed diet. The plasma levels of homocysteine (HCys) were also determined in the same individuals at the same time points. In addition, the subjects had completed a food frequency questionnaire (FFQ) describing their usual dietary habits before being placed on the dietary regimen. The blood levels of SAM, SAH, and HCys were compared with the dietary intakes of folate, vitamin B(6), fats, and calories, both prior to using the FFQ and during the experimental period. The results indicated that the intraindividual differences were very low, but the interindividual differences were large for the values of SAM, SAH, SAM:SAH ratios, and HCys. Interestingly, the blood levels of SAM and HCys were higher in men than in women and generally showed the expected correlations with folate intake i.e., positive for SAM and negative for HCys. The intakes of folate (276 microg/days) and B(6) (1.87 mg/days) during the 2-week experimental period were relatively low compared with the usual intakes of these vitamins (375 and 2.06 mg/day for folate and B(6), respectively) but correlated well with each other during both periods of the study. Surprisingly, both men and women showed a significant rise in erythrocyte SAM:SAH ratios as a function of age. In addition, the combined results from men and women, even adjusted for gender, showed significant correlations between HCys and both weight and body mass index. On the other hand, during the experimental period of the study, blood SAM levels were inversely correlated with the intakes of both fat and calories when the data for both men and women were combined and adjusted for gender. The blood determinations of SAM and related compounds showed a high degree of reproducibility over time and thus appear to provide a practical marker of methylation status for the assessment of cancer risk from dietary, environmental, and genetic factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401915

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  29 in total

1.  Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Brandilyn A Peters; Megan N Hall; Xinhua Liu; Faruque Parvez; Abu B Siddique; Hasan Shahriar; Mohammad Nasir Uddin; Tariqul Islam; Vesna Ilievski; Joseph H Graziano; Mary V Gamble
Journal:  J Nutr       Date:  2015-08-26       Impact factor: 4.798

2.  Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study.

Authors:  Eunyoung Cho; Steven H Zeisel; Paul Jacques; Jacob Selhub; Lauren Dougherty; Graham A Colditz; Walter C Willett
Journal:  Am J Clin Nutr       Date:  2006-04       Impact factor: 7.045

Review 3.  Metabolic control of epigenetics in cancer.

Authors:  Adam Kinnaird; Steven Zhao; Kathryn E Wellen; Evangelos D Michelakis
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

4.  Methylation potential associated with diet, genotype, protein, and metabolite levels in the Delta Obesity Vitamin Study.

Authors:  Jacqueline Pontes Monteiro; Carolyn Wise; Melissa J Morine; Candee Teitel; Lisa Pence; Anna Williams; Beverly McCabe-Sellers; Catherine Champagne; Jerome Turner; Beatrice Shelby; Baitang Ning; Joan Oguntimein; Lauren Taylor; Terri Toennessen; Corrado Priami; Richard D Beger; Margaret Bogle; Jim Kaput
Journal:  Genes Nutr       Date:  2014-04-24       Impact factor: 5.523

Review 5.  Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview.

Authors:  Zijun Wang; Hai Long; Christopher Chang; Ming Zhao; Qianjin Lu
Journal:  Cell Mol Life Sci       Date:  2018-07-04       Impact factor: 9.261

6.  Blood glutathione redox status and global methylation of peripheral blood mononuclear cell DNA in Bangladeshi adults.

Authors:  Megan M Niedzwiecki; Megan N Hall; Xinhua Liu; Julie Oka; Kristin N Harper; Vesna Slavkovich; Vesna Ilievski; Diane Levy; Alexander van Geen; Jacob L Mey; Shafiul Alam; Abu B Siddique; Faruque Parvez; Joseph H Graziano; Mary V Gamble
Journal:  Epigenetics       Date:  2013-05-17       Impact factor: 4.528

Review 7.  Minireview: Epigenomic Plasticity and Vulnerability to EDC Exposures.

Authors:  Cheryl Lyn Walker
Journal:  Mol Endocrinol       Date:  2016-06-29

8.  Associations between S-adenosylmethionine, S-adenosylhomocysteine, and colorectal adenoma risk are modified by sex.

Authors:  Martha J Shrubsole; Conrad Wagner; Xiangzhu Zhu; Lifang Hou; Lioudmila V Loukachevitch; Reid M Ness; Wei Zheng
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

9.  Effects of S-adenosylmethionine on liver methionine metabolism and steatosis with ethanol-induced liver injury in rats.

Authors:  Zuojiong Gong; Shaonan Yan; Ping Zhang; Yanqing Huang; Luwen Wang
Journal:  Hepatol Int       Date:  2008-07-25       Impact factor: 6.047

10.  A density-based proteomics sample fractionation technology: folate deficiency induced oxidative stress response in liver and brain.

Authors:  Wenkui Lan; Jayita Guhaniyogi; Marc J Horn; Jun Q Xia; Beverly Graham
Journal:  J Biomol Tech       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.